ArticleCancer science2024

Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101).

Kosuke Tsuji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.